Blaine Pharmaceuticals, Inc., a distributor of over-the-counter pharmaceutical products, stands out as a company that capitalizes on unique product opportunities by building trust and strong relationships with healthcare professionals and their partners.
Founded in 1955, Blaine still carries the name of its founder, Moreland Blaine, who made his start by specially formulating products for local pharmacists and physicians. He recognized the value of relationships with healthcare professionals, a position Blaine continues to follow over 50 years later.
While it remains Blaine's focus to partner with healthcare professionals to educate the consumer, the company now offers greater accessibility by making products available in front of the counter. All Blaine products are manufactured to high standards. In fact, the company's supplements are Pharmaceutical Grade® Quality, exceeding requirements set for supplements and reinforcing Blaine's commitment to quality and safety.
Blaine Pharmaceuticals is the maker of Mag-Ox 400®, the number one doctor recommended magnesium supplement on the market today. In 2006, Blaine introduced the DiaSense™ family of nutritional supplements specifically formulated to improve the health and well being of those living with—or at-risk for—type 2 diabetes. PediaSense™ ReliaDose® was introduced in 2007 as the company's first product targeted for infants. Today, the Blaine team remains committed to cultivating relationships with physicians, pharmacists, patients, wholesalers, retailers, and other business partners to promote current products and lay the foundation for future endeavors.
Officers
Alex Blaine, CEO
Alex, the son of Blaine's founder, is highly involved within the medical community. He is a firm supporter of the need for clinical studies to support Blaine's products. One of his passions has been to educate the medical community and the public about the medical benefits of nutritional supplementation. He has worked with health advocates, healthcare associations, and legislatures to raise awareness of the clinically documented studies once overlooked by healthcare professionals.
Alex assumed his position of CEO in 1985. He helped to invigorate the magnesium category and spark sales for its longstanding, flagship product—Mag-Ox 400®. Alex holds a bachelor of arts degree from the University of Kentucky.
Vincent J. Gilday Jr., COO and CFO
Vincent J. Gilday Jr. is chief operating officer and chief financial officer at Blaine and is responsible for the company's finances, administration, information services, procurement, and relationships with the financial community. He also serves as the company's primary liaison with its external business partners.
Before joining Blaine, Gilday served as president and chief financial officer of a wholly owned subsidiary of Black Box Corporation. Prior to that he served in a number of senior management positions in manufacturing, distribution, and public accounting. Gilday is a graduate of Thomas More College with a bachelor of arts degree in accounting and is a certified public accountant.
Mark Rinker, Vice President of Sales
Mark Rinker is the vice president of sales at Blaine and is responsible for all trade relations, market development activities, and sales management as well as evaluating and developing new products to complement the existing Blaine product portfolio. Previously, Mark served as Director of International Sales for Blaine where he established successful Canadian operations and distribution with major retailers in Canada. He also expanded Blaine's distribution to the United Kingdom and other countries in Europe, Japan, South Africa, Central America, Mexico and Korea.
Prior to Blaine, Mark worked as director of Canadian operations for Omron Healthcare. At Omron, Rinker successfully established Canadian operations and was part of an outstanding sales force. Prior to Omron, Rinker worked as a national sales manager with Magna-Pak, Inc., and as a business development manager at Becton Dickinson Canada. Mark graduated from University of Western Ontario with a Bachelor of Administration.
Dreama Kirby, Chief Marketing Officer
Dreama Kirby is the chief marketing officer at Blaine. She is responsible for the strategic marketing direction of Blaine and its product lines. Dreama is also highly involved with the clinical and market development of future products. She joined Blaine in 2002.
Her previous experience includes Ethicon Endo-Surgery and cardiovascular molecular biology research at the University of Cincinnati Cardiovascular Center and Children's Hospital Research Foundation. Dreama holds an MBA in marketing/international business from the University of Cincinnati and a bachelor of science in biology.